Hepatic lipase activity is increased in non‐alcoholic fatty liver disease beyond insulin resistance

Abstract

The higher hepatic lipase activity in NAFLD patients contributes to a more atherogenic profile linked to increased cardiovascular risk, beyond the insulin resistance and the reduction in adiponectin.